Heike Bruck
Overview
Explore the profile of Heike Bruck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruck H, von Kiel C
Dtsch Med Wochenschr
. 2023 Feb;
148(5):230-240.
PMID: 36848886
Autoimmune diagnostics plays a central role in the detection of various acute and/or chronic diseases in both nephrology and rheumatology, which are associated with high morbidity and mortality if left...
2.
Volker L, Kaufeld J, Balduin G, Merkel L, Kuhne L, Eichenauer D, et al.
J Thromb Haemost
. 2023 Jan;
21(3):559-572.
PMID: 36696206
Background: The von Willebrand factor-directed nanobody caplacizumab has greatly changed the treatment of immune thrombotic thrombocytopenic purpura (iTTP) in recent years. Data from randomized controlled trials established efficacy and safety....
3.
Orth-Alampour S, Gayrard N, Salem S, Bhargava S, Jankowski V, Jover B, et al.
Basic Res Cardiol
. 2021 Oct;
116(1):57.
PMID: 34647168
The adrenal glands participate in cardiovascular (CV) physiology and the pathophysiology of CV diseases through their effects on sodium and water metabolism, vascular tone and cardiac function. In the present...
4.
Kaufeld J, Brinkkoetter P, Schreiber A, Jabs W, Bieringer M, Bruck H, et al.
Ann Hematol
. 2020 Sep;
100(12):3051-3052.
PMID: 32997190
No abstract available.
5.
Gajjala P, Bruck H, Noels H, Heinze G, Ceccarelli F, Kribben A, et al.
J Mol Med (Berl)
. 2019 Aug;
97(10):1451-1463.
PMID: 31385015
Chronic kidney disease (CKD) may progress to end-stage renal disease (ESRD) at different pace. Early markers of disease progression could facilitate and improve patient management. However, conventional blood and urine...
6.
Gronewold J, Todica O, Seidel U, Volsek M, Kribben A, Bruck H, et al.
PLoS One
. 2016 Nov;
11(11):e0166530.
PMID: 27835681
Background: As kidney and brain functions decline with aging, chronic kidney disease (CKD) and dementia are becoming increasing health burdens worldwide. Among the risk factors for cognitive impairment, CKD is...
7.
Gronewold J, Todica O, Klafki H, Seidel U, Kaltwasser B, Wiltfang J, et al.
Mol Neurobiol
. 2016 Nov;
54(9):7194-7203.
PMID: 27796755
Decreased β-amyloid (Aβ) clearance from the brain has been suggested to contribute to cerebral Aβ accumulation in Alzheimer's disease. Based on the idea of a dynamic Aβ equilibrium in different...
8.
Gronewold J, Klafki H, Baldelli E, Kaltwasser B, Seidel U, Todica O, et al.
Mol Neurobiol
. 2015 May;
53(5):3136-3145.
PMID: 26019016
Disturbed brain-to-blood elimination of β-amyloid (Aβ) promotes cerebral Aβ accumulation in Alzheimer's disease. Considering that the kidneys are involved in Aβ elimination from the blood, we evaluated how chronic kidney...
9.
Salem S, Jankowski V, Asare Y, Liehn E, Welker P, Raya-Bermudez A, et al.
Circulation
. 2015 Mar;
131(16):1426-34.
PMID: 25810338
Background: The renin-angiotensin system and especially the angiotensin peptides play a central role in blood pressure regulation. Here, we hypothesize that an as-yet unknown peptide is involved in the action...
10.
Seidel U, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, et al.
PLoS One
. 2014 Mar;
9(3):e91176.
PMID: 24614180
Background: Quality of life (QoL) impairment is a well-known consequence of chronic kidney disease (CKD). The factors influencing QoL and late life functional health are poorly examined. Methods: Using questionnaires...